Cargando…
Evidence-based clinical use of insulin premixtures
Brazil is expected to have 19.6 million patients with diabetes by the year 2030. A key concept in the treatment of type 2 diabetes mellitus (T2DM) is establishing individualized glycemic goals based on each patient’s clinical characteristics, which impact the choice of antihyperglycemic therapy. Tar...
Autores principales: | Tambascia, Marcos Antônio, Nery, Márcia, Gross, Jorge Luiz, Ermetice, Mariana Narbot, de Oliveira, Carolina Piras |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016222/ https://www.ncbi.nlm.nih.gov/pubmed/24011173 http://dx.doi.org/10.1186/1758-5996-5-50 |
Ejemplares similares
-
Hypoglycemia incidence and awareness among insulin-treated patients with diabetes: the HAT study in Brazil
por: Lamounier, Rodrigo Nunes, et al.
Publicado: (2018) -
Saponin-Rich Plant Premixture Supplementation Is as Efficient as Ionophore Monensin Supplementation Under Experimental Eimeria spp Challenge in Broiler Chicken
por: Benarbia, Mohammed el Amine, et al.
Publicado: (2022) -
Degludec: the new ultra-long insulin analogue
por: Tambascia, Marcos Antonio, et al.
Publicado: (2015) -
Depression and alexithymia on weight perception in patients with metabolic syndrome and type 2 diabetes
por: de Oliveira Regina, Maria Cristina, et al.
Publicado: (2017) -
Homa-adiponectin index as useful surrogate marker in the screeening of insulin resistance
por: Vilela, Brunna Sullara, et al.
Publicado: (2015)